A Legacy of Innovation… The Technology of the Future

The first useful deflectable tip catheter was pioneered by Will Webster more than three decades ago. Ever since then, the Webster name has been synonymous with industry-leading design and craftsmanship in diagnostic and therapeutic cardiac catheters. In 1993, revolutionary Biosense technology paved the way for important advancements in cardiac imaging. Combining these technology leaders as Biosense Webster, Inc. within the Johnson & Johnson family of companies has significantly enhanced both the science and the clinical application of electrophysiology.

Biosense Webster continues the tradition of advanced, meticulously crafted diagnostic and therapeutic catheters. No other company offers as many EP catheters and custom catheter designs, including both traditional and soft-tip models. Breakthrough designs such as the LASSO™ Circular Mapping Catheter clearly demonstrate a strong commitment to atrial fibrillation technology—the most promising next frontier in electrophysiology.

The company has also become a world leader in software and hardware systems for three-dimensional cardiac mapping and navigation. The CARTO™ XP EP Navigation and Ablation System provides unprecedented views into the electrical activity of the heart through real-time data on three-dimensional, color-coded cardiac maps. The CARTO XP System also makes possible precise, real-time tracking of catheter location and diagnosis.

As part of its collaborative relationship with the electrophysiology community, Biosense Webster provides an unusual depth of customer support. Services include professional education and training, clinical support and training for new users, ongoing technical support for existing customers, plus educational, regulatory, and critical industry information.

Extensive experience, consistent focus and advanced technology continue to make Biosense Webster a global leader in the diagnosis and treatment of cardiac arrhythmias.